[
  {
    "ts": "2026-02-05T02:07:57+00:00",
    "headline": "Dow Jones Futures: Google Beats Views, Huge AI Spending Stuns",
    "summary": "The rotation out of techs continued in a divided stock market, but Eli Lilly jumped. Google rose late on earnings and huge capital spending plans.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-techs-falling-eli-lilly-soars-google-earnings-capital-spending/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "677bdc22-05ed-3320-ac7a-79b8c08a86d0",
      "content": {
        "id": "677bdc22-05ed-3320-ac7a-79b8c08a86d0",
        "contentType": "STORY",
        "title": "Dow Jones Futures: Google Beats Views, Huge AI Spending Stuns",
        "description": "",
        "summary": "The rotation out of techs continued in a divided stock market, but Eli Lilly jumped. Google rose late on earnings and huge capital spending plans.",
        "pubDate": "2026-02-05T02:07:57Z",
        "displayTime": "2026-02-05T02:07:57Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/677bdc22-05ed-3320-ac7a-79b8c08a86d0/dow-jones-futures-google.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967",
          "originalWidth": 1012,
          "originalHeight": 572,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L4l8MOhcHp7duSBQOsJEMQ--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967.cf.webp",
              "width": 1012,
              "height": 572,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UPNT3tjMLQLXH6GEUSs.Jg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-techs-falling-eli-lilly-soars-google-earnings-capital-spending/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "BE"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "CRUS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T04:05:55+00:00",
    "headline": "Dow Jones Futures Fall; Google Beats Views, Huge AI Spending Stuns",
    "summary": "The rotation out of techs continued in a divided stock market, but Eli Lilly jumped. Google rose late on earnings and huge capital spending plans.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-techs-falling-eli-lilly-soars-google-earnings-capital-spending/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "677bdc22-05ed-3320-ac7a-79b8c08a86d0",
      "content": {
        "id": "677bdc22-05ed-3320-ac7a-79b8c08a86d0",
        "contentType": "STORY",
        "title": "Dow Jones Futures Fall; Google Beats Views, Huge AI Spending Stuns",
        "description": "",
        "summary": "The rotation out of techs continued in a divided stock market, but Eli Lilly jumped. Google rose late on earnings and huge capital spending plans.",
        "pubDate": "2026-02-05T04:05:55Z",
        "displayTime": "2026-02-05T04:05:55Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/677bdc22-05ed-3320-ac7a-79b8c08a86d0/dow-jones-futures-fall-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967",
          "originalWidth": 1012,
          "originalHeight": 572,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L4l8MOhcHp7duSBQOsJEMQ--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967.cf.webp",
              "width": 1012,
              "height": 572,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UPNT3tjMLQLXH6GEUSs.Jg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-techs-falling-eli-lilly-soars-google-earnings-capital-spending/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMD"
            },
            {
              "symbol": "BE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "CRUS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T03:38:34+00:00",
    "headline": "Why Eli Lilly Stock Soared Today",
    "summary": "The healthcare giant gained nearly $100 billion in market value.",
    "url": "https://www.fool.com/investing/2026/02/04/why-eli-lilly-stock-is-up-today/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "47a77f00-e8e8-3502-af6a-4f0458922b24",
      "content": {
        "id": "47a77f00-e8e8-3502-af6a-4f0458922b24",
        "contentType": "STORY",
        "title": "Why Eli Lilly Stock Soared Today",
        "description": "",
        "summary": "The healthcare giant gained nearly $100 billion in market value.",
        "pubDate": "2026-02-05T03:38:34Z",
        "displayTime": "2026-02-05T03:38:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/b792e1f49374dc8f1f2a872f5210122e",
          "originalWidth": 1400,
          "originalHeight": 934,
          "caption": "A healthcare professional is looking at medical supplies. ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iohU2ON1aFYggmt2nhe9MA--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/b792e1f49374dc8f1f2a872f5210122e.cf.webp",
              "width": 1400,
              "height": 934,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gq5fA0kI1RXhS4uCxWmmqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/b792e1f49374dc8f1f2a872f5210122e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/04/why-eli-lilly-stock-is-up-today/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-eli-lilly-stock-soared-033834668.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T04:37:01+00:00",
    "headline": "Is Eli Lilly (LLY) Still Attractive After Obesity Drug Headlines And A US$1,107 Share Price?",
    "summary": "If you are wondering whether Eli Lilly's share price already reflects what you are hearing about weight loss and other treatments, or if there could still be value on the table, this article walks through what the numbers are saying right now. The stock last closed at US$1,107.12, with returns of 8.1% over 7 days, 6.3% over 30 days, 2.5% year to date, 32.4% over 1 year, and a very large gain over 5 years. Recent headlines have focused heavily on Eli Lilly's obesity and diabetes drug...",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-still-attractive-043701975.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "76eec517-69b3-3a03-a8f0-60e06a0a38eb",
      "content": {
        "id": "76eec517-69b3-3a03-a8f0-60e06a0a38eb",
        "contentType": "STORY",
        "title": "Is Eli Lilly (LLY) Still Attractive After Obesity Drug Headlines And A US$1,107 Share Price?",
        "description": "",
        "summary": "If you are wondering whether Eli Lilly's share price already reflects what you are hearing about weight loss and other treatments, or if there could still be value on the table, this article walks through what the numbers are saying right now. The stock last closed at US$1,107.12, with returns of 8.1% over 7 days, 6.3% over 30 days, 2.5% year to date, 32.4% over 1 year, and a very large gain over 5 years. Recent headlines have focused heavily on Eli Lilly's obesity and diabetes drug...",
        "pubDate": "2026-02-05T04:37:01Z",
        "displayTime": "2026-02-05T04:37:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-still-attractive-043701975.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-still-attractive-043701975.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T08:26:58+00:00",
    "headline": "Eli Lilly and Company Q4 Earnings Call Highlights",
    "summary": "Eli Lilly and Company (NYSE:LLY) executives highlighted strong 2025 performance, continued demand for its incretin medicines, and an expanding late-stage pipeline during the company’s Q4 2025 earnings conference call. Management also outlined 2026 financial guidance that anticipates higher revenue d",
    "url": "https://www.marketbeat.com/instant-alerts/eli-lilly-and-company-q4-earnings-call-highlights-2026-02-05/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "6da620fb-a60b-3ff9-a156-46499365355f",
      "content": {
        "id": "6da620fb-a60b-3ff9-a156-46499365355f",
        "contentType": "STORY",
        "title": "Eli Lilly and Company Q4 Earnings Call Highlights",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE:LLY) executives highlighted strong 2025 performance, continued demand for its incretin medicines, and an expanding late-stage pipeline during the company’s Q4 2025 earnings conference call. Management also outlined 2026 financial guidance that anticipates higher revenue d",
        "pubDate": "2026-02-05T08:26:58Z",
        "displayTime": "2026-02-05T08:26:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/4896a73d5f97078f97737a29264eae52",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Eli Lilly and Company logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZBike2mUCJL3A7TJ3j5YfA--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/4896a73d5f97078f97737a29264eae52.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xwWXBJrcUH6CNcgB4DM1DQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/4896a73d5f97078f97737a29264eae52.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/eli-lilly-and-company-q4-earnings-call-highlights-2026-02-05/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-company-q4-earnings-082658839.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T07:28:24+00:00",
    "headline": "Eli Lilly (LLY) Skyrockets as Profits Soar 95%",
    "summary": "We recently published 10 Stocks With Monster Gains. Eli Lilly and Company (NYSE:LLY) was one of the top performers on Wednesday. Eli Lilly soared by 10.33 percent on Wednesday to close at $1,107.12 apiece after profits last year nearly doubled on the back of strong sales from Zepbound and Mounjaro, alongside a 23 percent revenue […]",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-skyrockets-profits-072824114.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "24a1d120-1296-3308-8708-da9d13554ce6",
      "content": {
        "id": "24a1d120-1296-3308-8708-da9d13554ce6",
        "contentType": "STORY",
        "title": "Eli Lilly (LLY) Skyrockets as Profits Soar 95%",
        "description": "",
        "summary": "We recently published 10 Stocks With Monster Gains. Eli Lilly and Company (NYSE:LLY) was one of the top performers on Wednesday. Eli Lilly soared by 10.33 percent on Wednesday to close at $1,107.12 apiece after profits last year nearly doubled on the back of strong sales from Zepbound and Mounjaro, alongside a 23 percent revenue […]",
        "pubDate": "2026-02-05T07:28:24Z",
        "displayTime": "2026-02-05T07:28:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f4f6ab0951c1038aa2303274fb6c0b9d",
          "originalWidth": 1280,
          "originalHeight": 853,
          "caption": "Eli Lilly (LLY) Skyrockets as Profits Soar 95%",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OdUZhzJneaC3psvAqDZt0Q--~B/aD04NTM7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/f4f6ab0951c1038aa2303274fb6c0b9d.cf.webp",
              "width": 1280,
              "height": 853,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/igPuOk294DrUoWTvXb9e3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f4f6ab0951c1038aa2303274fb6c0b9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-skyrockets-profits-072824114.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-skyrockets-profits-072824114.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T09:05:00+00:00",
    "headline": "Can Pfizer Crash the Lilly and Novo Nordisk Weight-Loss Party?",
    "summary": "Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can.",
    "url": "https://www.fool.com/investing/2026/02/05/can-pfizer-crash-the-lilly-and-novo-nordisk-weight/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "5c75ef06-3987-32bc-a8c6-8660442c1dfd",
      "content": {
        "id": "5c75ef06-3987-32bc-a8c6-8660442c1dfd",
        "contentType": "STORY",
        "title": "Can Pfizer Crash the Lilly and Novo Nordisk Weight-Loss Party?",
        "description": "",
        "summary": "Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can.",
        "pubDate": "2026-02-05T09:05:00Z",
        "displayTime": "2026-02-05T09:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/6a9cd55787a1959dc1ae5736f6015ba3",
          "originalWidth": 1024,
          "originalHeight": 652,
          "caption": "Pfizer name and logo on glass.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ou0vmboVTY4v6hAwUyQKDA--~B/aD02NTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/6a9cd55787a1959dc1ae5736f6015ba3.cf.webp",
              "width": 1024,
              "height": 652,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pIHRcKLCwjnZWY4iY2UXnQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/6a9cd55787a1959dc1ae5736f6015ba3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/05/can-pfizer-crash-the-lilly-and-novo-nordisk-weight/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-crash-lilly-novo-nordisk-090500888.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T09:00:00+00:00",
    "headline": "BioPhorum announces formation of Strategic Advisory Board to accelerate industry collaboration",
    "summary": "BioPhorum, the pharmaceutical industry's most trusted collaborative network for change, today announces the formation of its inaugural Strategic Advisory Board.",
    "url": "https://finance.yahoo.com/news/biophorum-announces-formation-strategic-advisory-090000803.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b74b8036-e57b-3086-a16f-7d4fbc4303f0",
      "content": {
        "id": "b74b8036-e57b-3086-a16f-7d4fbc4303f0",
        "contentType": "STORY",
        "title": "BioPhorum announces formation of Strategic Advisory Board to accelerate industry collaboration",
        "description": "",
        "summary": "BioPhorum, the pharmaceutical industry's most trusted collaborative network for change, today announces the formation of its inaugural Strategic Advisory Board.",
        "pubDate": "2026-02-05T09:00:00Z",
        "displayTime": "2026-02-05T09:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/dbfe71d9e524f3517a76456543af8b32",
          "originalWidth": 400,
          "originalHeight": 154,
          "caption": "The biopharmaceutical industry’s most trusted collaborative network for change.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YQ5a592cBQAVu47wcmBSyA--~B/aD0xNTQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/dbfe71d9e524f3517a76456543af8b32.cf.webp",
              "width": 400,
              "height": 154,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.WcqSIj7bTMRoMOWaeVblw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/dbfe71d9e524f3517a76456543af8b32.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biophorum-announces-formation-strategic-advisory-090000803.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biophorum-announces-formation-strategic-advisory-090000803.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "SARTF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T10:15:07+00:00",
    "headline": "US Stock Market Today S&P 500 Futures Nudge Higher As Rate Jitters Linger",
    "summary": "The Morning Bull - US Market Morning Update Thursday, Feb, 5 2026 US stock futures are pointing slightly higher this morning, with contracts tied to the S&P 500 and Nasdaq 100 up around 0.1% to 0.3%, as investors weigh a mixed set of signals on growth and interest rates. ADP private payrolls showed just 22,000 new jobs in January 2026, hinting that hiring is slowing, while the ISM Services PMI held at 53.8, meaning services businesses are still growing and facing rising input costs. At the...",
    "url": "https://finance.yahoo.com/news/us-stock-market-today-p-101507736.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "841a6643-95af-30c7-81f2-8e4298da3beb",
      "content": {
        "id": "841a6643-95af-30c7-81f2-8e4298da3beb",
        "contentType": "STORY",
        "title": "US Stock Market Today S&P 500 Futures Nudge Higher As Rate Jitters Linger",
        "description": "",
        "summary": "The Morning Bull - US Market Morning Update Thursday, Feb, 5 2026 US stock futures are pointing slightly higher this morning, with contracts tied to the S&P 500 and Nasdaq 100 up around 0.1% to 0.3%, as investors weigh a mixed set of signals on growth and interest rates. ADP private payrolls showed just 22,000 new jobs in January 2026, hinting that hiring is slowing, while the ISM Services PMI held at 53.8, meaning services businesses are still growing and facing rising input costs. At the...",
        "pubDate": "2026-02-05T10:15:07Z",
        "displayTime": "2026-02-05T10:15:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFax.1EIpS7VVYvaDN0jRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OB69YGFZw788CGHTsahrkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/us-stock-market-today-p-101507736.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/us-stock-market-today-p-101507736.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "ADP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T05:38:28+00:00",
    "headline": "LLY Q4 Deep Dive: Obesity Medicines, Pipeline Progress, and Market Expansion Drive Outperformance",
    "summary": "Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 42.6% year on year to $19.29 billion. The company’s full-year revenue guidance of $81.5 billion at the midpoint came in 4.8% above analysts’ estimates. Its non-GAAP profit of $7.54 per share was 8.7% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/lly-q4-deep-dive-obesity-053828099.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "cb8da0f2-6647-3808-9277-de7553a5cf09",
      "content": {
        "id": "cb8da0f2-6647-3808-9277-de7553a5cf09",
        "contentType": "STORY",
        "title": "LLY Q4 Deep Dive: Obesity Medicines, Pipeline Progress, and Market Expansion Drive Outperformance",
        "description": "",
        "summary": "Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 42.6% year on year to $19.29 billion. The company’s full-year revenue guidance of $81.5 billion at the midpoint came in 4.8% above analysts’ estimates. Its non-GAAP profit of $7.54 per share was 8.7% above analysts’ consensus estimates.",
        "pubDate": "2026-02-05T05:38:28Z",
        "displayTime": "2026-02-05T05:38:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "LLY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/y7jUkGcVljBpqcrgSnimZQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fw6rZdJZ6CRFkLxhDmPhew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lly-q4-deep-dive-obesity-053828099.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lly-q4-deep-dive-obesity-053828099.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T13:09:02+00:00",
    "headline": "Dow Jones Futures Fall, Bitcoin Dives Below $70,000; Google AI Spending Stuns",
    "summary": "Google earnings were strong, but AI spending stunned. Bitcoin continues to dive while the stock market is deeply divided.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-google-earnings-capital-spending/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "677bdc22-05ed-3320-ac7a-79b8c08a86d0",
      "content": {
        "id": "677bdc22-05ed-3320-ac7a-79b8c08a86d0",
        "contentType": "STORY",
        "title": "Dow Jones Futures Fall, Bitcoin Dives Below $70,000; Google AI Spending Stuns",
        "description": "",
        "summary": "Google earnings were strong, but AI spending stunned. Bitcoin continues to dive while the stock market is deeply divided.",
        "pubDate": "2026-02-05T13:09:02Z",
        "displayTime": "2026-02-05T13:09:02Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/677bdc22-05ed-3320-ac7a-79b8c08a86d0/dow-jones-futures-fall-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967",
          "originalWidth": 1012,
          "originalHeight": 572,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L4l8MOhcHp7duSBQOsJEMQ--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967.cf.webp",
              "width": 1012,
              "height": 572,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UPNT3tjMLQLXH6GEUSs.Jg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-google-earnings-capital-spending/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BE"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "CRUS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:37:49+00:00",
    "headline": "Hims launches $49 compounded copy of Wegovy weight-loss pill",
    "summary": "By Amina Niasse NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health will start offering compounded copies of Novo Nordisk's new Wegovy weight-loss pill at an introductory price",
    "url": "https://finance.yahoo.com/news/exclusive-hims-hers-health-launches-133502712.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "9aece461-54b9-3a70-a6a4-c9f75f2d7ad7",
      "content": {
        "id": "9aece461-54b9-3a70-a6a4-c9f75f2d7ad7",
        "contentType": "STORY",
        "title": "Hims launches $49 compounded copy of Wegovy weight-loss pill",
        "description": "",
        "summary": "By Amina Niasse NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health will start offering compounded copies of Novo Nordisk's new Wegovy weight-loss pill at an introductory price",
        "pubDate": "2026-02-05T14:37:49Z",
        "displayTime": "2026-02-05T14:44:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/5503a009a9f9fe7be6c9be59e35c193e",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ooo_MupmnixCfOueFQz.sQ--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/5503a009a9f9fe7be6c9be59e35c193e.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iqW1gna30ewYRyIq057U_w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/5503a009a9f9fe7be6c9be59e35c193e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/exclusive-hims-hers-health-launches-133502712.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/exclusive-hims-hers-health-launches-133502712.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:36:21+00:00",
    "headline": "Hims stock surges as Wegovy pill copy offered at $49, Novo shares fall",
    "summary": "Investing.com -- Hims and Hers Health (NYSE:HIMS) stock surged 19% on Thursday after the telehealth company announced it will offer compounded versions of Novo Nordisk’s (NYSE:NVO) new Wegovy pill at an introductory price of $49 per month, significantly undercutting the brand-name product.",
    "url": "https://finance.yahoo.com/news/hims-stock-surges-wegovy-pill-143621717.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "149de3a4-01a0-3096-842a-6b69185e1ed1",
      "content": {
        "id": "149de3a4-01a0-3096-842a-6b69185e1ed1",
        "contentType": "STORY",
        "title": "Hims stock surges as Wegovy pill copy offered at $49, Novo shares fall",
        "description": "",
        "summary": "Investing.com -- Hims and Hers Health (NYSE:HIMS) stock surged 19% on Thursday after the telehealth company announced it will offer compounded versions of Novo Nordisk’s (NYSE:NVO) new Wegovy pill at an introductory price of $49 per month, significantly undercutting the brand-name product.",
        "pubDate": "2026-02-05T14:36:21Z",
        "displayTime": "2026-02-05T14:36:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hims-stock-surges-wegovy-pill-143621717.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hims-stock-surges-wegovy-pill-143621717.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T14:00:52+00:00",
    "headline": "Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results",
    "summary": "Stock futures are mixed and have shown modest signs of stabilization after a sharp downturn in software and AI-related technology stocks yesterday, prompting some investors to treat the technology selloff that pressured equities broadly as a buying opportunity. Against that backdrop, defensive sectors and commodity-linked assets have drawn interest, particularly as gold reclaimed levels above $5,000 an ounce, reflecting continued demand for safe havens amid uncertainty. Claim 50% Off TipRanks Pr",
    "url": "https://finance.yahoo.com/news/morning-movers-eli-lilly-rises-140052306.html",
    "source": "TipRanks",
    "provider": "yfinance",
    "raw": {
      "id": "ed66cd00-8d90-3e73-9d2a-c99e7d64e7e8",
      "content": {
        "id": "ed66cd00-8d90-3e73-9d2a-c99e7d64e7e8",
        "contentType": "STORY",
        "title": "Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results",
        "description": "",
        "summary": "Stock futures are mixed and have shown modest signs of stabilization after a sharp downturn in software and AI-related technology stocks yesterday, prompting some investors to treat the technology selloff that pressured equities broadly as a buying opportunity. Against that backdrop, defensive sectors and commodity-linked assets have drawn interest, particularly as gold reclaimed levels above $5,000 an ounce, reflecting continued demand for safe havens amid uncertainty. Claim 50% Off TipRanks Pr",
        "pubDate": "2026-02-05T14:00:52Z",
        "displayTime": "2026-02-05T14:00:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/tipranks_452/097670a128888e1828116a13ce464258",
          "originalWidth": 192,
          "originalHeight": 192,
          "caption": "https://www.tipranks.com/news/the-fly/morning-movers-eli-lilly-rises-boston-scientific-falls-after-quarterly-results-thefly",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/paL.s16_PAor.Ex2OGgnDQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/097670a128888e1828116a13ce464258.cf.webp",
              "width": 192,
              "height": 192,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z7N7z9dCk4A19oWcLwtVRQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/097670a128888e1828116a13ce464258.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TipRanks",
          "url": "https://www.tipranks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/morning-movers-eli-lilly-rises-140052306.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/morning-movers-eli-lilly-rises-140052306.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "FOX"
            },
            {
              "symbol": "FOXA"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "CMG"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "FTV"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "CTSH"
            },
            {
              "symbol": "EFX"
            },
            {
              "symbol": "SLAB"
            },
            {
              "symbol": "TXN"
            },
            {
              "symbol": "JCI"
            },
            {
              "symbol": "YUM"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "GEHC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T08:00:00+00:00",
    "headline": "The most valuable up-and-coming GLP-1s",
    "summary": "Late-stage GLP-1 candidates from Eli Lilly, Novo Nordisk and Amgen have a combined net present value of $68 billion.",
    "url": "https://www.pharmavoice.com/news/big-pharmas-most-valuable-glp-1-lilly-novo-amgen/811416/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "cd53fe93-e7ff-3228-a566-db9693bb002d",
      "content": {
        "id": "cd53fe93-e7ff-3228-a566-db9693bb002d",
        "contentType": "STORY",
        "title": "The most valuable up-and-coming GLP-1s",
        "description": "",
        "summary": "Late-stage GLP-1 candidates from Eli Lilly, Novo Nordisk and Amgen have a combined net present value of $68 billion.",
        "pubDate": "2026-02-05T08:00:00Z",
        "displayTime": "2026-02-05T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/8e12c1f802486fd31dc269484cd802b1",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RgQv48EhJ9s.6dwJDNEzPA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/8e12c1f802486fd31dc269484cd802b1.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.lVcErHY4W.sj_fXC0ROsA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/8e12c1f802486fd31dc269484cd802b1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/big-pharmas-most-valuable-glp-1-lilly-novo-amgen/811416/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/big-pharma-most-valuable-coming-080000627.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]